• P-ISSN 0974-6846 E-ISSN 0974-5645

Indian Journal of Science and Technology


Indian Journal of Science and Technology

Year: 2022, Volume: 15, Issue: 19, Pages: 923-926

Original Article

In Silico Interaction Studies of Various Antioxidant Molecules with MAO-B Protein – A Potent Secondary Drug Target in Parkinson’s Disease

Received Date:05 December 2021, Accepted Date:21 April 2022, Published Date:25 May 2022


Objective: Parkinson’s Disease (PD) remains to be the second prominent neurodegenerative disorder affecting the oldster populace. Administration of dopamine is the existing therapeutic choice to treat PD disorder. Contradictorily, administrated dopamine is readily oxidised by monoamine oxidase type B (MAOB) protein. Thus, MAOB is a potent secondary drug target for treating PD. The main objective of this present investigation is to compare, analyse and conclude the best adjuvant drug for the PD therapy. Methods: Molecules with high antioxidant properties were shortlisted for this study. This in-silico study was carried out by utilising several bioinformatics tools such as Patch Dock, Discovery studio software and CPHmodels-3.0. Findings: Alpha Tocopherol and Essential long chain fatty acids exhibited a good affinity binding scores than the existing adjuvant therapy drugs. The atomic contact energy of the docked complex of Alpha Tocopherol - MAOB is -373.83 Kcal/Mol and Docosahexaenoic Acid (DHA) - MAOB is -322.77 Kcal/Mol. Alpha Tocopherol and DHA was more significant than the Safinamide-MAOB complex with the atomic energy of - 302 Kcal/Mol. Novelty: The present study has comprehensively compared the in-silico interaction of various PD adjuvant drugs with the MAOB target and revealed the better MAOB inhibitor with their detailed interaction map and atomic contact energy.

Keywords: Parkinson’s Disease; MAOB; Essential fatty acids; Selegiline; Tocopherol; MAOB inhibitors


  1. NLDR, Quiroga-Varela A, Fernanzo-Santiago R, Monje M, Trigo-Damas I, Blanco-Prieto M, et al. Advances in Parkinson’s Disease: 200years later. Frontiers in Neuroanatomy. 2020;12(113):1–14. doi: 10.3389/fnana.2018.00113
  2. Rui Q, Ni H, Li D, Gao R, Chen G. The Role of LRRK2 in Neurodegeneration of Parkinson Disease. Current Neuropharmacology. 2018;16(9):1348–1357. Available from: https://dx.doi.org/10.2174/1570159x16666180222165418
  3. Alecu I, Bennett SAL. Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease. Frontiers in Neuroscience. 2019;13(328):1–22. doi: 10.3389/fnins.2019.00328
  4. Jin CF, Wang ZZ, Chen KZ, Xu TF, Hao GF. Computational Fragment-Based Design Facilitates Discovery of Potent and Selective Monoamine Oxidase-B (MAO-B) Inhibitor. Journal of Medicinal Chemistry. 2020;63(23):15021–15036. Available from: https://dx.doi.org/10.1021/acs.jmedchem.0c01663
  5. Elkamhawy A, Woo J, Gouda NA, Kim J, Nada H, Roh EJ, et al. Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress. Antioxidants. 2021;10(10):1604. Available from: https://dx.doi.org/10.3390/antiox10101604
  6. Schirinzi T, Martella G, Imbriani P, Lazzaro GD, Franco D, Colona VL, et al. Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence. Frontiers in Neurology. 2019;10(148). Available from: https://dx.doi.org/10.3389/fneur.2019.00148
  7. Sun Q, Qu Y, Chen X, Xu MM. Relationship between high dietary fat intake and Parkinson’s disease risk: a meta-analysis. Neural Regeneration Research. 2019;14(12):2156. Available from: https://dx.doi.org/10.4103/1673-5374.262599
  8. Angelova PR, Horrocks MH, Klenerman D, Gandhi S, Abramov AY, Shchepinov MS. Lipid peroxidation is essential for α-synuclein-induced cell death. Journal of Neurochemistry. 2015;133(4):582–589. Available from: https://dx.doi.org/10.1111/jnc.13024
  9. Avallone R, Vitale G, Bertolotti M. Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials. International Journal of Molecular Sciences. 2019;20(17):4256. Available from: https://dx.doi.org/10.3390/ijms20174256


© 2022 Poornima & Sumathy. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Published By Indian Society for Education and Environment (iSee)


Subscribe now for latest articles and news.